Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishment of an in vitro hairless guinea pig dermal model.

PloS one·2026
Same author

Synthetic mucus biomaterials enable localized therapeutic antibody delivery in inflammatory bowel disease.

APL bioengineering·2026
Same author

Dual Dupilumab and Omalizumab Therapy in Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma: Real-World Experience From an Eight-Patient Case Series.

The Australasian journal of dermatology·2025
Same author

In vitro methods for evaluation of sulfur mustard on cell senescence.

Chemico-biological interactions·2025
Same author

Ultralow Dose Rituximab Combined With IVIG Is Safe and Effective in Pemphigus Vulgaris: Single-Center Review of 24 Patients.

The Australasian journal of dermatology·2025
Same author

Nanoparticles reveal permanent and reversible changes to lymph node biomechanics during inflammatory response.

Biomaterials·2025

Related Experiment Video

Updated: Oct 30, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.0K

Microfluidic systems to study tissue barriers to immunotherapy.

Ann Ramirez1, Mayowa Amosu1, Priscilla Lee1

  • 1Department of Bioengineering, University of Maryland, College Park, MD, USA.

Drug Delivery and Translational Research
|July 3, 2021
PubMed
Summary

Microfluidic devices create 3D tissue models for studying the immune system, advancing immunotherapy development for diseases like cancer. These advanced models better mimic in vivo conditions than 2D models.

Keywords:
Biological barriersDevicesDiseaseIn vitroModel systems

More Related Videos

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
12:55

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation

Published on: December 9, 2021

3.5K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.0K

Related Experiment Videos

Last Updated: Oct 30, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.0K
A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
12:55

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation

Published on: December 9, 2021

3.5K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.0K

Area of Science:

  • Immunology
  • Biomedical Engineering
  • Tissue Engineering

Background:

  • Traditional 2D cell models do not fully replicate the complex 3D tissue structure crucial for immune cell function.
  • Understanding the immune microenvironment is key to developing effective immunotherapies for various diseases.

Purpose of the Study:

  • To review microfluidic devices designed for studying the immune system.
  • To highlight the role of 3D microfluidic models in advancing immunotherapy research and development.

Main Methods:

  • Summarizing diverse microfluidic devices for immune system modeling.
  • Including models of immune organs (bone marrow, lymph node), disease states (cancer, IBD), and therapeutic applications.
  • Focusing on how microfluidics elucidate immune microenvironment interactions and influence immunotherapy efficacy.

Main Results:

  • Microfluidic technology enables the creation of intricate 3D tissue models.
  • These models offer more physiologically relevant in vitro systems compared to 2D models.
  • Microfluidic platforms are instrumental in understanding immune responses and optimizing immunotherapies.

Conclusions:

  • Microfluidic-based 3D tissue models are crucial for advancing immunotherapy research.
  • These models provide deeper insights into immune system physiology and disease pathology.
  • Continued development of microfluidic systems will accelerate the design of novel and improved immunotherapies.